genedrive plc (LON:GDR – Get Free Report)’s share price was down 11.2% during mid-day trading on Monday . The company traded as low as GBX 0.50 ($0.01) and last traded at GBX 0.53 ($0.01). Approximately 9,043,583 shares changed hands during trading, a decline of 52% from the average daily volume of 18,940,135 shares. The stock had previously closed at GBX 0.60 ($0.01).
genedrive Stock Up 4.4%
The firm has a market cap of £5.35 million, a price-to-earnings ratio of -0.24 and a beta of -0.04. The company has a debt-to-equity ratio of 0.35, a quick ratio of 5.52 and a current ratio of 4.60. The business’s 50-day moving average is GBX 0.51 and its 200-day moving average is GBX 1.09.
About genedrive
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
Featured Stories
- Five stocks we like better than genedrive
- How to trade using analyst ratings
- Beware The Death Cross: 3 Stocks Triggering This Spooky Signal
- What is MarketRank™? How to Use it
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- Why is the Ex-Dividend Date Significant to Investors?
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
